Newly emerging variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
are continuously posing high global public health concerns and panic resulting in waves of …

ABSTRAK Pandemi Coronavirus disease 2019 (COVID-19) telah berlangsung sejak Maret
2020 hingga saat ini sudah hampir dua tahun melanda dunia, tak terkecuali Indonesia …

The Omicron variant of SARS-CoV-2 was detected in October 2021 and exhibited high
transmissibility, immune evasion, and reduced severity when compared to the earlier …

SARS‐CoV‐2 virus has infected nearly 300 M people worldwide and has been associated
with over 6 M deaths by March 2022. Since the virus emergence in December 2019 in …

Background Early treatment of coronavirus disease 2019 (COVID-19) with remdesivir in high-
risk patients, including those with immunosuppression of different causes, has not been …

Background With the widespread transmission of the Omicron SARS-CoV-2 variant,
reinfections have become increasingly common. Here, we explored the role of immunity …

Tixagevimab-cilgavimab is authorized for preexposure prophylaxis against coronavirus
disease 2019 (COVID-19) in immunocompromised hosts. Herein, we report the clinical …

Multiple introductions of SARS-COV-2 Omicron variant BA. 1 and BA. 1.1. lineages to
Finland were detected in early December 2021. Within 3 weeks, Omicron overtook Delta as …

Serosurveillance helps establish reopening guidelines and determine the immunity levels in
different populations to reach herd immunity. Then, there is an urgent need to estimate …

Objectives To identify the SARS-CoV-2 variants Delta and Omicron during the fourth wave of
the COVID-19 pandemic in Mexico using samples taken from 19 locations in 18 out of the 32 …